PAVmed (PAVM) PT Lowered to $17 at Ascendiant Capital
Tweet Send to a Friend
Ascendiant Capital analyst Edward Woo lowered the price target on PAVmed (NASDAQ: PAVM) to $17.00 (from $20.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
